Akorbi announces aggressive growth strategy in early 2012

NewsGuard 100/100 Score

Akorbi, one of the health insurance industry's largest suppliers of translation and interpretation services, announced an aggressive growth strategy in early 2012 that included the addition of multilingual and technology consulting staffing services.  The goal was to support clients globally with staffing needs in the technology, translation services, and professional service arenas.  The move proved to be highly successful and played a significant role in the company's ability to double revenue in 2012.

Today, Akorbi's technology and multilingual staffing division supports an array of clients that include one of the world's largest technology companies, a large conglomerate of security service companies and a top Dallas-area school district.  Currently, Akorbi manages payroll for more than 300 contractors in the school district alone. 

"The expansion of services, our multilingual capabilities and our consultative approach have given us a competitive edge and allowed us to grow even in a struggling economy," said Claudia Mirza , chief executive officer of Akorbi. "We are constantly looking for ways to better support our clients."

Akorbi's growth in 2012 was also impacted by the company's new technology, research and development division which includes full-time system architects and professional developers.  This team is responsible for creating custom technology solutions for clients, as well as for overseeing Akorbi's proprietary and patented translation management system.

Yet another key growth factor was Akorbi's new compliance division, which proved to be highly successful in supporting clients in highly regulated industries with an on-site compliance officer.  The division provides support in a wide range of legal issues, including HIPAA; Centers for Medicare & Medicaid Service rules; healthcare reform mandates; quality management; fraud, waste and abuse.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook